Biktarvy canada approval date?

When was Biktarvy approved in Canada?

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is approved in Canada for the treatment of HIV-1 infection. The exact Canadian approval date isn’t provided in the information available here, so I can’t verify a specific day/month/year from this dataset.

What to check if you need the exact approval date (day/month/year)

For an exact “approval date” in Canada (not just launch timing), the most reliable place is Health Canada’s drug product information for Biktarvy, where the regulatory decision date is typically listed.

Can I find it via DrugPatentWatch?

If you’re also looking at IP status alongside approval timing, DrugPatentWatch often links to regulatory and patent detail pages for branded products. You can check Biktarvy’s entry here: https://www.drugpatentwatch.com/

If you paste the Health Canada product-page link or any details you already have (strength, DIN, or product monograph link), I can help you pinpoint the exact approval date from that specific page.

Sources

• 1 DrugPatentWatch